These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23006125)

  • 1. Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
    Grau-López L; Granada ML; Raïch-Regué D; Naranjo-Gómez M; Borràs-Serres FE; Martínez-Cáceres E; Ramo-Tello C
    BMC Neurol; 2012 Sep; 12():103. PubMed ID: 23006125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
    Stein MS; Ward GJ; Butzkueven H; Kilpatrick TJ; Harrison LC
    Mol Med; 2018 May; 24(1):27. PubMed ID: 30134801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effects of Vitamin D in multiple sclerosis.
    Correale J; Ysrraelit MC; Gaitán MI
    Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
    Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
    Muris AH; Rolf L; Broen K; Hupperts R; Damoiseaux J; Smolders J
    J Steroid Biochem Mol Biol; 2016 Nov; 164():254-257. PubMed ID: 26598277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH; Søndergaard HB; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
    Smolders J; Thewissen M; Peelen E; Menheere P; Tervaert JW; Damoiseaux J; Hupperts R
    PLoS One; 2009 Aug; 4(8):e6635. PubMed ID: 19675671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
    Røsjø E; Steffensen LH; Jørgensen L; Lindstrøm JC; Šaltytė Benth J; Michelsen AE; Aukrust P; Ueland T; Kampman MT; Torkildsen Ø; Holmøy T
    J Neurol; 2015 Dec; 262(12):2713-21. PubMed ID: 26429571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
    Becker J; Callegaro D; Lana-Peixoto MA; Talim N; Vidaletti T; de Paula Corrêa M; Gomes I
    J Neurol Sci; 2016 Apr; 363():236-9. PubMed ID: 27000256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.
    Smolders J; Menheere P; Thewissen M; Peelen E; Tervaert JW; Hupperts R; Damoiseaux J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):243-6. PubMed ID: 20211254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 25(OH) vitamin D level in Relapsing-Remitting Multiple Sclerosis and clinically isolated syndrome groups.
    Küçük A; Bir LS; Tekin S; Demir S
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):281-288. PubMed ID: 35405046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
    Rodi M; Dimisianos N; de Lastic AL; Sakellaraki P; Deraos G; Matsoukas J; Papathanasopoulos P; Mouzaki A
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
    Rito Y; Flores J; Fernández-Aguilar A; Escalante-Membrillo C; Barboza MA; Amezcua L; Corona T
    Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
    Soilu-Hänninen M; Airas L; Mononen I; Heikkilä A; Viljanen M; Hänninen A
    Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
    Smolders J; Peelen E; Thewissen M; Menheere P; Damoiseaux J; Hupperts R
    Mult Scler; 2014 Apr; 20(4):433-7. PubMed ID: 23959712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
    Smolders J; Menheere P; Kessels A; Damoiseaux J; Hupperts R
    Mult Scler; 2008 Nov; 14(9):1220-4. PubMed ID: 18653736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C; Zeng Z; Wang B; Guo S
    J Nutr Health Aging; 2018; 22(1):38-43. PubMed ID: 29300420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.